Literature DB >> 197442

Comparative in vitro studies on corticotropin releasing activity of vasopressin and hypothalamic median eminence extract.

B Lutz-Bucher, B Koch, C Mialhe.   

Abstract

The in vitro corticotropic releasing effects of vasopressin (VP) and hypothalamic median eminence (HME) extract were compared as a function of their concentration and preincubation and incubation times. Whereas HME extract augmented the ACTH secretion from non-preincubated adenohypophyses, VP released corticotropin from the pituitaries only after a 2 h preincubation period. The disappearance of endogenous VP during the preincubation time rendered the gland responsive. The maximal stimulation of ACTH secretion by VP was markedly less than that induced by HME extract. The results suggest the presence of VP receptor sites in the anterior pituitary (AP) which are probably different from the receptor sites of the hypothalamic corticotropin releasing factor (CRF).

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 197442     DOI: 10.1159/000122666

Source DB:  PubMed          Journal:  Neuroendocrinology        ISSN: 0028-3835            Impact factor:   4.914


  4 in total

1.  The effect of repeated electroconvulsive shock on corticosterone responses to centrally acting pharmacological stimuli in the male rat.

Authors:  J A Steiner; D G Grahame-Smith
Journal:  Psychopharmacology (Berl)       Date:  1980       Impact factor: 4.530

2.  Two distinct corticotrophin releasing activities of vasopressin.

Authors:  J C Buckingham
Journal:  Br J Pharmacol       Date:  1985-01       Impact factor: 8.739

3.  Endocrine concomitants of sweating and sweat depression.

Authors:  V Candas; G Brandenberger; B Lutz-Bucher; M Follenius; J P Libert
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1984

4.  Vasopressin stimulation of adrenocorticotropin hormone (ACTH) in humans. In vivo bioassay of corticotropin-releasing factor (CRF) which provides evidence for CRF mediation of the diurnal rhythm of ACTH.

Authors:  R A Salata; D B Jarrett; J G Verbalis; A G Robinson
Journal:  J Clin Invest       Date:  1988-03       Impact factor: 14.808

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.